Search Clinical Trials
583,492 trials
ID
Status
Phase
Title
Sponsor
NCT07573345
Pain and Upper Extremity Function in Smartphone and Digital Game AddictionIstinye UniversityRecruiting
NCT07573345Recruiting
—
Pain and Upper Extremity Function in Smartphone and Digital Game AddictionIstinye University
NCT07573150
Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Depression in Children Undergoing TonsillectomyNational Institute on Drug Abuse (NIDA)Not Yet Recruiting
NCT07573150Not Yet Recruiting
—
Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Dep...National Institute on Dru...
NCT07574034
A Single Patient Study of Sapropterin for Multisystem Smooth Muscle Dysfunction SyndromeGregor AndelfingerNot Yet RecruitingNot Applicable
NCT07574034Not Yet Recruiting
Not Applicable
A Single Patient Study of Sapropterin for Multisystem Smooth Muscle Dysfunction...Gregor Andelfinger
NCT07573644
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Brachial Access in the Endovascular Treatment of Peripheral Arterial LesionUniversity Hospital, BrestNot Yet RecruitingNot Applicable
NCT07573644Not Yet Recruiting
Not Applicable
A Prospective Randomized Study Comparing the Safety of Percutaneous and Open Bra...University Hospital, Bres...
NCT07573007
Epidural Catheter Placement Techniques by Anesthesia Residents: Success and ComplicationsMarmara University Pendik Training and Research HospitalNot Yet Recruiting
NCT07573007Not Yet Recruiting
—
Epidural Catheter Placement Techniques by Anesthesia Residents: Success and Comp...Marmara University Pendik...
NCT07573917
Improving Insulin Sensitivity in Patients With Type 2 Diabetes Via Repeated Cold-induced Shivering ThermogenesisMaastricht University Medical CenterRecruitingNot Applicable
NCT07573917Recruiting
Not Applicable
Improving Insulin Sensitivity in Patients With Type 2 Diabetes Via Repeated Cold...Maastricht University Med...
NCT07572136
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing B-cell Acute Lymphoblastic Leukemia (B-ALL)National Cancer Institute (NCI)Not Yet RecruitingPhase 1
NCT07572136Not Yet Recruiting
Phase 1
Phase I Dose Escalation Study of Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T...National Cancer Institute...
NCT07572539
The Accuracy of Peripheral Perfusion Index and Inferior Vena Cava Collapsibility Index for Predicting Hypotension in Patients Undergoing Shoulder Arthroscopy in Beach Chair Position:Tanta UniversityActive Not Recruiting
NCT07572539Active Not Recruiting
—
The Accuracy of Peripheral Perfusion Index and Inferior Vena Cava Collapsibility...Tanta University
NCT07573774
"Body, Mind, and Self: ACT With Psychoeducation for Female Students Facing Eating Challenges"Menoufia UniversityCompletedNot Applicable
NCT07573774Completed
Not Applicable
"Body, Mind, and Self: ACT With Psychoeducation for Female Students Facing Eatin...Menoufia University
NCT07572396
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients With High-Risk HPV (Hr-HPV) and Either (1) ASC-US or (2) Low-Grade Squamous Intraepithelial Lesions (LSIL)Amplexd Therapeutics, Inc.RecruitingPhase 2
NCT07572396Recruiting
Phase 2
Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients With High-Ri...Amplexd Therapeutics, Inc...
NCT07573059
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated PatientsImmedica Pharma US IncRecruitingNot Applicable
NCT07573059Recruiting
Not Applicable
Evaluation of the Safety of Loargys Arginine Test System in Loargys-treated Pati...Immedica Pharma US Inc
NCT07573215
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic AdenocarcinomaRevolution Medicines, Inc.Unknown
NCT07573215Unknown
—
Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metast...Revolution Medicines, Inc...
NCT07573462
A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy InfantsPfizerNot Yet RecruitingPhase 3
NCT07573462Not Yet Recruiting
Phase 3
A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy...Pfizer
NCT07574242
Effect of vitk2 on Atopic Dermatitis Pediatrics PatientsOctober 6 UniversityCompletedNot Applicable
NCT07574242Completed
Not Applicable
Effect of vitk2 on Atopic Dermatitis Pediatrics PatientsOctober 6 University
NCT07573228
Impact of Obesity on Microvascular Insulin Action and Cardiorespiratory Fitness in Type 1 DiabetesUniversity of VirginiaRecruitingNot Applicable
NCT07573228Recruiting
Not Applicable
Impact of Obesity on Microvascular Insulin Action and Cardiorespiratory Fitness...University of Virginia
NCT07573748
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospital of Huai'anNot Yet RecruitingNot Applicable
NCT07573748Not Yet Recruiting
Not Applicable
Apple Vision Pro-Assisted Vascular Identification in Lung SurgeryThe Second People's Hospi...
NCT07572383
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive FibrosisNational Heart, Lung, and Blood Institute (NHLBI)RecruitingPhase 2
NCT07572383Recruiting
Phase 2
Advanced Imaging to Assess the Effect of Immunosuppression on Progressive Fibros...National Heart, Lung, and...
NCT07572045
Promoting Interventions for Climate Change to Upscale Resilience in District BadinDr Jai Kumar DasNot Yet RecruitingNot Applicable
NCT07572045Not Yet Recruiting
Not Applicable
Promoting Interventions for Climate Change to Upscale Resilience in District Bad...Dr Jai Kumar Das
NCT07574294
Dual REmission in Moderate-to-SEvere asthMa and Nasal PolypsAzienda Ulss 2 Marca TrevigianaCompleted
NCT07574294Completed
—
Dual REmission in Moderate-to-SEvere asthMa and Nasal PolypsAzienda Ulss 2 Marca Trev...
NCT07574047
MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma.Swiss Cancer InstituteNot Yet RecruitingPhase 4
NCT07574047Not Yet Recruiting
Phase 4
MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for...Swiss Cancer Institute
Result Breakdown
Not yet recruiting9 (45%)
Recruiting6 (30%)
Completed3 (15%)
Active, not recruiting1 (5%)
Unknown1 (5%)
not_applicable9 (45%)
Not Specified6 (30%)
Phase 22 (10%)
Phase 11 (5%)
Phase 31 (5%)
Phase 41 (5%)